What is Intravene?
Since its inception in 1989, Intravene has carved out a significant niche in the delivery of high-quality intravenous care, including antibiotic, hydration, biologic, and IVIG therapies. By operating dedicated facilities in key regions such as Lynchburg, Danville, Roanoke, and Charlottesville, the company provides a cost-effective alternative to traditional hospital-based infusion services. Their multidisciplinary team of physicians, pharmacists, and nurses ensures that patient-centric care remains the cornerstone of their operations, effectively bridging the gap between clinical necessity and accessible healthcare infrastructure.
How much funding has Intravene raised?
Intravene has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Intravene
PPP
Public-Private Partnership
What's next for Intravene?
The infusion of capital marks a pivotal moment for Intravene as it transitions into a more aggressive phase of late-stage growth. By leveraging this strategic financing, the company is expected to optimize its facility network and potentially expand its service offerings to meet the rising demand for outpatient medical care. As the healthcare sector continues to prioritize cost-efficiency and patient convenience, Intravene's focus on specialized, non-hospital settings positions it as a critical player in the regional medical ecosystem. Future initiatives will likely center on scaling operational efficiencies and strengthening the financial assistance programs that define their patient-first approach.
See full Intravene company page
